CINECA IRIS Institutional Research Information System

TUCCORI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.557
AS - Asia 2.701
EU - Europa 2.220
SA - Sud America 436
AF - Africa 262
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.213
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.407
SG - Singapore 918
CN - Cina 683
IT - Italia 654
HK - Hong Kong 397
SE - Svezia 371
BR - Brasile 332
DE - Germania 262
GB - Regno Unito 255
BG - Bulgaria 160
IN - India 149
VN - Vietnam 147
TR - Turchia 111
CI - Costa d'Avorio 106
FI - Finlandia 104
FR - Francia 87
CA - Canada 81
RU - Federazione Russa 79
JP - Giappone 57
SN - Senegal 48
NL - Olanda 45
NG - Nigeria 43
MX - Messico 39
UA - Ucraina 38
AU - Australia 32
ID - Indonesia 32
PL - Polonia 31
BD - Bangladesh 28
IQ - Iraq 25
KR - Corea 25
BE - Belgio 23
AR - Argentina 22
CO - Colombia 20
AT - Austria 18
ES - Italia 17
CL - Cile 16
VE - Venezuela 16
ZA - Sudafrica 16
PK - Pakistan 15
MY - Malesia 14
EC - Ecuador 13
PT - Portogallo 13
IR - Iran 12
SA - Arabia Saudita 12
UZ - Uzbekistan 12
JO - Giordania 11
LT - Lituania 9
CH - Svizzera 8
PH - Filippine 8
PY - Paraguay 8
DZ - Algeria 7
IE - Irlanda 7
KE - Kenya 7
MA - Marocco 7
CZ - Repubblica Ceca 6
IL - Israele 6
TN - Tunisia 6
AZ - Azerbaigian 5
EG - Egitto 5
JM - Giamaica 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
ET - Etiopia 4
GR - Grecia 4
LV - Lettonia 4
RO - Romania 4
TT - Trinidad e Tobago 4
AL - Albania 3
BB - Barbados 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
EU - Europa 3
HN - Honduras 3
HR - Croazia 3
PE - Perù 3
TH - Thailandia 3
UY - Uruguay 3
AO - Angola 2
BJ - Benin 2
EE - Estonia 2
GE - Georgia 2
GH - Ghana 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
NI - Nicaragua 2
NP - Nepal 2
PS - Palestinian Territory 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
Totale 10.189
Salva come PNG Salva come JPEG
Città #
Ashburn 677
Singapore 525
Santa Clara 405
Hong Kong 392
Chandler 310
Dallas 275
Ann Arbor 255
Woodbridge 240
Shanghai 238
Fairfield 225
Houston 165
Sofia 158
New York 133
Beijing 126
Boardman 122
Abidjan 106
Los Angeles 104
Florence 99
Wilmington 97
Serra 95
London 93
Milan 90
Seattle 83
Munich 80
Princeton 76
Cambridge 73
Lawrence 65
Medford 56
Istanbul 53
Dakar 48
Ottawa 45
Pisa 42
Lagos 41
Helsinki 39
Ho Chi Minh City 38
Buffalo 37
Izmir 37
Frankfurt am Main 35
Tokyo 34
Rome 33
Dong Ket 32
Jacksonville 32
Turku 32
Redwood City 29
Bremen 28
Kent 24
Hanoi 23
Warsaw 23
Washington 23
Nanjing 22
Brussels 21
Chicago 21
Lancaster 21
Mumbai 21
Hyderabad 20
Redondo Beach 20
Des Moines 19
Massa 19
São Paulo 19
Council Bluffs 18
Rio de Janeiro 18
Hefei 17
Fuzhou 16
Jakarta 16
San Diego 16
Düsseldorf 15
Denver 14
Mexico City 13
Ogden 13
San Francisco 13
Dearborn 12
Lauterbourg 12
Santiago 12
Chennai 11
Johannesburg 11
Amman 10
Mountain View 10
Nanchang 10
Norwalk 10
Nuremberg 10
Phoenix 10
Seoul 10
Tashkent 10
Toronto 10
Atlanta 9
Baghdad 9
Belo Horizonte 9
Curitiba 9
Livorno 9
Marseille 9
Modugno 9
Vancouver 9
Cascina 8
Kuala Lumpur 8
Manchester 8
Paris 8
San Jose 8
Sydney 8
Bengaluru 7
Bogotá 7
Totale 6.745
Salva come PNG Salva come JPEG
Nome #
Acute portal vein thrombosis precipitated by indomethacin in a HCV-positive elderly patient 248
Quality of adverse drug reaction (QADRA) reports: an algorithm to appraise the efficiency of spontaneous reporting systems in pharmacovigilance 233
Emerging role of Cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions 197
Gabapentin-induced severe myopathy: a case report 184
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 183
Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management 173
Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy) 171
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 170
Role of A2a adenosine in the regulation of colonic motility in normal human colon 162
Clinical differences among the elderly admitted to the emergency department for accidental or unexplained falls and syncope 160
Direct health care costs among patients with rheumatoid arthritis before and after the initiation of treatment with JAKi in Tuscany: The LEONARDO study 160
Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats 158
The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications 155
Longitudinal adherence trajectories to biologic disease modifying anti-rheumatic drugs in Tuscany, Italy 155
Adherence with regulatory resolutions on prevention of NSAIDS-related gastrointestinal injury in Italy 149
Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing 149
Cholecystokinin CCK2 receptors mediate the peptide's inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway 146
Adherence to mesalazine and identification of patients with ulcerative colitis in healthcare administrative databases of Tuscany (Italy) 146
CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon 142
Antibiotic Drugs and Unresolved Sensory Side Effects: Analysis of Eudravigilance Database of Suspected Adverse Drug Reaction Reports 142
Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases 139
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 138
Diagnostic delay, effectiveness and safety outcomes in a real-world cohort of patients with Crohn's disease: Data from administrative databases in Tuscany, Italy 135
Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials 134
Progressive multifocal leukoencephalopathy and anti-CD20 monoclonal antibodies: What do we know after 20 years of rituximab 133
Functional Neuroplasticity in Acute Diverticulitis: Differential Regulation of Colonic Excitatory Nerve Pathways By Cyclooxygenase Isoforms 132
Olfactory and gustatory impairments in COVID-19 patients: Role in early diagnosis and interferences by concomitant drugs 132
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline 131
Raynaud’s Phenomenon Associated with Calcitonin Gene-Related Peptide (CGRP) Antagonists: a Disproportionality Analysis on VigiBase 129
Time to biologic treatment and to total colectomy associated with diagnostic delay in ulcerative colitis: Analysis of an Italian regional administrative healthcare database 124
Acute severe myopathy following single intravenous infusion of omeprazole 123
Listening Social Media for Pharmacovigilance Objectives: Which Usefulness? 123
Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study) 121
Adverse drug reactions in oncoLogy: intEnsive monitoring program on biotechnological anD taRget therapies in Oncologic patientS-ALEXANDROS observational study 120
Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy 120
Utilization patterns and healthcare accesses of JAKi used in rheumatoid arthritis patients in Tuscany: The LEONARDO study 119
IntenSive Monitoring Program of TeratOgen and Non-Teratogen Risk of Drugs During Pregnancy: the STORK Project 118
Anticoagulant Therapy and Risk of Bleeding in Patients with Atrial Fibrillation of Four Italian Regions: The TYRION Study 118
Role of the A(2B) receptor-adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rat 117
Bleeding Related to Oral Anticoagulant Drugs as Cause of Emergency Department Admission: Analysis of Data from the Tuscan MEREAFaPS Network 116
Recommendations by the Tuscan Health Authority to Use Infliximab-Biosimilar in the Clinical Practice: Safety Impact 113
Potential and Actual Drug-Drug Interactions in Elderly Patients Admitted to an Emergency Department: Data from the ANCESTRAL-ED Study 112
A clinician network for sharing patients experiences in pharmacovigilance: the PHARMACOWIKILANCE project 111
Disproportionality Analysis of ‘‘Early-Onset’’ Tardive Dyskinesia Stratified by Time to Onset Using FAERS Database. 108
An overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future 107
Estimation of Theoretical Cost Preventability Achievable with an Effective Pharmacovigilance Activity in a Pharmacovigilance Regional Centre in Italy 107
SSRIs and birth defects: Can a new statistical approach resolve old controversies? 105
Fatal hepatitis after long-term pulse itraconazole treatment for onychomycosis: a case report with review of literature 104
Checkpoint inhibitors and progressive multifocal leukoencephalopathy: friends of foes? 104
Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients 104
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases 104
THE ECONOMIC IMPACT OF THE INTRODUCTION OF INFLIXIMAB-BIOSIMILAR: AN EMPIRICAL ANALYSIS USING THE TUSCANY HEALTHCARE ADMINISTRATIVE DATABASES 104
Characterization of the Risk of Bleeding with Novel Oral Anticoagulants and Warfarin: A Pilot Case-Control Study 102
Erratum to: Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System (Drug Safety, (2023), 46, 3, (283-295), 10.1007/s40264-022-01269-x) 100
Anti-tumor Necrosis Factor Drugs and Risk of Lymphoma in Patients with Inflammatory Bowel Disease 100
Exploring the relationship between utilization patterns of biologic disease-modifying anti-rheumatic drugs and disease activity in rheumatoid arthritis patients 98
The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy 98
Anticoagulant Therapy in Patients with Atrial Fibrillation and Risk of Bleeding: Interim Analysis: Tyrion Study 97
Update of Certolizumab Pegol Safety Profile: A Systematic Review and Meta-Analysis 97
Discontinuation rate to biologic and targeted synthetic DMARDs in rheumatoid arthritis patients: Systematic review and meta-analysis 96
Statin-associated psychiatric adverse events: a case/non case evaluation of an Italian database of spontaneous adverse drug reaction reporting 94
Italian Emergency Department Visits and Hospitalizations for Outpatients’ Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study) 93
The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance 92
A Model-Based Analysis on Direct Costs of Adverse Drug Events and Related Cost-Savings Achievable by their Prevention in Tuscany, Italy 92
Haemorrhagic gastritis and bleeding following rofecoxib administration 89
Risk of hospitalisation associated with benzodiazepines and z-drugs in Italy: a nationwide multicentre study in emergency departments 89
Use of antiseizure medications and safety of branded versus generic formulations: A comparative study on Tuscan administrative databases 89
Analysis of the Drug Related Emergency Department Admissions in Tuscany: The FARO Project 88
Fatal Fat Overload Syndrome Following Intravenous Lipid Emulsion Administration as Antidote in Suspected Anesthetic Intoxication: A Fatal Medication Error. 88
Switching from infliximab-originator to infliximab-biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy 88
A regulatory overview of biosimilars across selected countries 85
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project 85
Use of Biological Drugs for Psoriasis: A Drug-Utilization Study Using Tuscan Administrative Databanks 83
Evaluation of drug-utilization and healthcare facilities use in patients with ulcerative colitis and treated with biologic therapy using data of an Italian healthcare administrative database: Results from michelangelo study 83
Muscular adverse drug reactions associated with proton pump inhibitors: a disproportionality analysis using the Italian National Network of Pharmacovigilance database 82
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis 80
Severe Cardiac Events Following Treatment with Trastuzumab in Women with Breast Cancer: A Meta-Analysis of Clinical Trials and Cohort Studies 79
Assessment of Healthcare Facilities Associated with JAKi Drugs Used in Rheumatoid Arthritis Patients in Tuscany, Italy: The LEONARDO 72
Potential missed diagnoses of Crohn's disease in tertiary care: impact on drug utilization and healthcare facilities use 72
Oral Presentation: Signal of Hypertension Associated with COVID-19 Vaccination: VigiBase (R) Data and Evidence from Real World 72
Supporting the Spontaneous Reporting by Health Care Professionals of the University Hospital of Pisa, Italy: a Pilot Project from the Unit of Adverse Drug Reactions Monitoring 70
Communicating Drug Safety 66
Tixagevimab + cilgavimab against SARS-CoV-2: the preclinical and clinical development and real-world evidence 64
Fat overload syndrome following intravenous lipid emulsion administration as antidote in suspected anesthetic intoxication: insights from a clinical and forensic case experience 62
Biosimilars approvals by thirteen regulatory authorities: A cross-national comparison 60
Lessons learnt from the preclinical discovery and development of ensitrelvir as a COVID-19 therapeutic option 60
Oral Presentation: Accesses to Emergency Department and Hospitalizations in New Users of Biologic Therapies for Ulcerative Colitis in Tuscany: The MICHELANGELO Study 57
COVID-19 Vaccines and Thromboembolic Events with Thrombocytopenia: Data from Italian Pharmacovigilance Public Database 57
Signals of Possibly Persistent Gustatory, Olfactory and Auditory Adverse Drug Reactions to Antibiotic Drugs: A Disproportionality Analysis Using the EudraVigilance Database 52
A Cross-National Comparison of Biosimilars Pricing in Argentina, Australia, Brazil, and Italy 45
Unresolved Gustatory, Olfactory and Auditory Adverse Drug Reactions to Antibiotic Drugs: A Signal Detection Analysis on Publicly Accessible Eudravigilance Data 44
Risk of Hospitalization Associated with Cardiovascular Medications in the Elderly Italian Population: A Nationwide Multicenter Study in Emergency Departments 42
Authors’ response: Inhibiting IL-6 in COVID-19: we are not sure that sgp130(fc) can affect only the trans-signaling receptor pathway of IL-6 41
Totale 10.391
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.810
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.810
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021278 0 0 0 0 0 9 16 32 25 22 19 155
2021/2022948 17 42 86 88 156 134 32 45 53 23 64 208
2022/20231.300 173 219 85 98 115 125 32 73 264 2 108 6
2023/20241.023 64 64 83 35 122 171 98 53 42 50 116 125
2024/20253.287 38 124 112 244 270 400 246 112 339 391 329 682
2025/20261.979 418 272 349 273 442 225 0 0 0 0 0 0
Totale 10.391